Impact of Swiprosin-1/Efhd2 on Adult Hippocampal Neurogenesis
Stem Cell Reports, ISSN: 2213-6711, Vol: 10, Issue: 2, Page: 347-355
2018
- 8Citations
- 24Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef8
- Captures24
- Readers24
- 24
- Mentions1
- News Mentions1
- 1
Most Recent News
Impact of Swiprosin-1/Efhd2 on Adult Hippocampal Neurogenesis.
Stem Cell Reports. 2018 Jan 9; Authors: Regensburger M, Prots I, Reimer D, Brachs S, Loskarn S, Lie DC, Mielenz D, Winner B PubMed: 29337116 Submit Comment
Article Description
Swiprosin-1/Efhd2 (Efhd2) is highly expressed in the CNS during development and in the adult. EFHD2 is regulated by Ca 2+ binding, stabilizes F-actin, and promotes neurite extension. Previous studies indicated a dysregulation of EFHD2 in human Alzheimer's disease brains. We hypothesized a detrimental effect of genetic ablation of Efhd2 on hippocampal integrity and specifically investigated adult hippocampal neurogenesis. Efhd2 was expressed throughout adult neuronal development and in mature neurons. We observed a severe reduction of the survival of adult newborn neurons in Efhd2 knockouts, starting at the early neuroblast stage. Spine formation and dendrite growth of newborn neurons were compromised in full Efhd2 knockouts, but not upon cell-autonomous Efhd2 deletion. Together with our finding of severe hippocampal tauopathy in Efhd2 knockout mice, these data connect Efhd2 to impaired synaptic plasticity as present in Alzheimer's disease and identify a role of Efhd2 in neuronal survival and synaptic integration in the adult hippocampus.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2213671117305581; http://dx.doi.org/10.1016/j.stemcr.2017.12.010; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85040441651&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/29337116; https://linkinghub.elsevier.com/retrieve/pii/S2213671117305581; https://dx.doi.org/10.1016/j.stemcr.2017.12.010
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know